Finasteride 5 - Milpharm

Approved first in 1992 as Proscar®, finasteride was later released as Propecia® in 1997 for treating androgenetic alopecia. It functions by blocking the Type II 5-alpha reductase enzyme, which converts testosterone into DHT. Finasteride lowers serum DHT by up to 70% and increases testosterone by about 15%. While effective in hair loss prevention, its long-term use has been associated with psychosexual side effects, limiting its adoption in sports and non-medical contexts.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Finasteride 5 by Milpharm, consult with your doctor or healthcare professional.